Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.
Zivanovic O, Abramian A, Kullmann M, Fuhrmann C, Coch C, Hoeller T, Ruehs H, Keyver-Paik MD, Rudlowski C, Weber S, Kiefer N, Poelcher ML, Thiesler T, Rostamzadeh B, Mallmann M, Schaefer N, Permantier M, Latten S, Kalff J, Thomale J, Jaehde U, Kuhn WC. Zivanovic O, et al. Among authors: hoeller t. Int J Cancer. 2015 Feb 1;136(3):699-708. doi: 10.1002/ijc.29011. Epub 2014 Jun 17. Int J Cancer. 2015. PMID: 24895230 Clinical Trial.
Impact of Chemotherapy on Retroperitoneal Lymph Nodes in Ovarian Cancer.
Keyver-Paik MD, Arden JM, Lüders C, Thiesler T, Abramian A, Hoeller T, Hecking T, Ayub TH, Doeser A, Kaiser C, Kuhn W. Keyver-Paik MD, et al. Among authors: hoeller t. Anticancer Res. 2016 Apr;36(4):1815-24. Anticancer Res. 2016. PMID: 27069164 Clinical Trial.
Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution.
Hinz T, Ahmadzadehfar H, Wierzbicki A, Hoeller T, Wenzel J, Biersack HJ, Bieber T, Schmid-Wendtner MH. Hinz T, et al. Among authors: hoeller t. Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1316-25. doi: 10.1007/s00259-012-2139-3. Epub 2012 May 23. Eur J Nucl Med Mol Imaging. 2012. PMID: 22618833